ADVISORY BOARD MEMBERS (Japan Pharma)  

 

P. Reed

P. Reed Maurer   -  Lilly,  Merck,  PhRMA

 

Mr. Maurer is Chairman of the Board, aRigen Inc., President of International Alliances Limited LLC and Nippon Pharma Promotion KK, . He has lived in Japan since 1970, with executive positions including vice president of Eli Lilly Japan and vice president for Japan and China for Merck.

 

At Lilly, he directed company operation in Japan, increasing regional revenues five-fold. At Merck, he completed many pioneering transactions including the first purchase of a majority interest by a foreign company in a Japanese company traded on the first section of the Tokyo Stock Exchange, Banyu Pharmaceutical Company.

 

Reed was the first representative in Japan for the Pharmaceutical Research and Manufacturers of America (PhRMA), he has a long and distinguished history in the pharmaceutical industry in Japan.
Alan B. Bootes

Alan Bootes - Pfizer
 

Mr Alan Bootes is Chairman of the Board of Biosceptre. He recently retired after a 37 year career as a global manager with Pfizer Inc, the world’s leading Pharmaceutical and Animal Health products company.

 

Having built a reputation as an organization development and turnaround specialist through roles in Asia and Africa / Middle East, he subsequently led Pfizer country businesses in Taiwan, Canada (where he lifted annual sales from $50 million, #30 rank, to over $500 million and industry leader in 9 years) and lastly Japan, where in 5 years he took Pfizer from #10 to #1 rank in sales.
 

Alan also served as Chairman of the pharmaceutical industry associations in Taiwan, Canada and Japan, where he played a leading role in health policy development together with government officials and other stakeholders. He offers valuable experience in leadership, organization development and international marketing, especially in the Asian region.

 
   

Scott Balson, MD, (Pfizer, Novo-Nordisk)

 

Dr. Balson’s experience in Japan began practicing at Yakoda Air Force Base in 1993  He later served Pfizer as Medical Director  and has served as a Medical Affairs Director/Marking Division and Medical Science Director for Novo Nordisk. Dr. Balson is highly skill in reading, writing and speaking Japanese, which has been a strategic asset to the corporations he has served.